Source: Business Wire

Press Release: Apitope : Graves Diseases - Pipeline Review, H2 2016 - Key Companies are Apitope International NV, Nova Therapeutics LLC, Novartis AG, Omeros Corp & Rodos BioTarget GmbH - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Graves Diseases - Pipeline Review, H2 2016" report to their offering. Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking and pregnancy. Treatment inclu

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Hayley French's photo - CEO of Apitope

CEO

Hayley French

CEO Approval Rating

82/100

Read more